Citadel Advisors - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is and the CUSIP is 29266SAA4. A total of 15 filers reported holding ENDOLOGIX INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q3 2018$12,549,000
+99.0%
12,805,000
+102.3%
0.01%
+100.0%
Q2 2018$6,306,000
+59.5%
6,330,000
+55.1%
0.00%
+50.0%
Q1 2018$3,953,000
+25.7%
4,080,000
+25.5%
0.00%0.0%
Q4 2017$3,144,000
+0.6%
3,250,0000.0%0.00%0.0%
Q3 2017$3,124,000
+162.5%
3,250,000
+160.0%
0.00%
+100.0%
Q2 2017$1,190,000
-39.0%
1,250,000
-38.1%
0.00%
-50.0%
Q1 2017$1,950,000
-65.3%
2,020,000
-67.6%
0.00%
-66.7%
Q4 2016$5,624,000
+43.9%
6,230,000
+47.6%
0.01%
+50.0%
Q2 2016$3,907,000
+25.1%
4,221,0000.0%0.00%0.0%
Q1 2016$3,124,000
+90.1%
4,221,000
+111.0%
0.00%
+100.0%
Q4 2015$1,643,000
-84.7%
2,000,000
-83.3%
0.00%
-81.8%
Q3 2014$10,738,000
-32.6%
12,000,000
-24.5%
0.01%
-38.9%
Q2 2014$15,937,000
+4.4%
15,900,0000.0%0.02%0.0%
Q1 2014$15,269,000
-0.4%
15,900,000
+6.0%
0.02%
-10.0%
Q4 2013$15,338,00015,000,0000.02%
Other shareholders

There were no reported owners of ENDOLOGIX INC in Q3 2016.

NameSharesValueWeighting ↓
View complete list of ENDOLOGIX INC shareholders